Benzonatate
Product Images NDC 10135-632

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 10135-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Benzonatate, A Non-narcotic Antitussive Agent, Is 2, 5, 8, 11, 14, 17, 20, 23, 26- Nonaoxaoctacosan-28-yl P-(butylamino) Benzoate; With A Molecular Weight Of 603.7. (Benzonatate Capsules 01)

Chemical structure diagram of the active ingredient Benzonatate, showing its molecular formula C30H53NO11 with labeled functional groups including an aromatic ring, ether linkages, and an amine group.*

FDA Label Image

Principal Display Panelbenzonatatecapsules, Usp200 mg500 Capsulesrx Only (Benzonatate Capsules 02)

Benzonatate Capsules USP 200 mg label from Marlex Pharmaceuticals, Inc. The label shows the product name, strength of 200 mg, and indicates a package size of 500 capsules. Storage instructions specify 20° to 25°C with permitted excursions and advise dispensing in a light-resistant container. The label includes a barcode and states it is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.